摘要
Abstract
Objective To investigate the clinical effect and the quality of life of Peiyuan Tongnao capsule combined with conventional Western medicine benserazide and piribedil on patients with parkinson. Methods 68 cases of patients with Parkinson's disease treated in our hospital from June 2014 to June 2016 were randomly divided into the control group and the observation group, 34 cases in each group. The control group was treated with Yiduobasi hydrazine and piribedil, the ob-servation group was added with Peiyuan Tongnao capsule on the basis of control group. The UPDRS efficacy, TCM syndrome score and the daily living ability of ADL score after the treatment were compared. Results After treatment, the ADL score of two groups were all higher than before treatment (P<0.05), the scores of the treatment group were higher than those of the control group at the first four weeks, the difference was statistically significant (P<0.05). The total score of UPDRS 85.3% of the treatment group was higher than that 61.8% of the control group, and the difference was statistically significant (P<0.05). The effect of tremor, rigidity, insomnia, constipation, sweating symptoms in treatment group was significantly higher than those of the control group (P<0.05). Conclusion Peiyuan Tongnao capsule combined with benserazide and piribedil could effectively improve the clinical symptoms of patients with Parkinson's disease, improve the quality of life.关键词
帕金森病/培元通脑胶囊/多巴丝肼/吡贝地尔缓释片/生活质量/中西医结合Key words
Parkinson's disease/Peiyuan Tongnao capsule/benserazide/piribedil/quality of life/integrated traditional Chinese and Western分类
医药卫生
